Combination protocols remain exploratory and preclinical
Retatrutide functions as a triple receptor agonist (GLP-1, GIP, and glucagon) , helping to enhance satiety, reduce hunger signals, and optimize metabolic efficiency
Findings from the only randomized controlled trial involving liraglutide in this population were compromised due to incorrect participant randomization (Allison et al., 2023)
Short-Term: Reduction in insulin needs, weight loss, improved post-meal glucose levels, improved glucose levels overall, lower blood pressure and lipid levels
BPC-157: A Fundamentally Different Compound BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice